By 2026, personalized medicine in the US, driven by advancements in gene editing and targeted therapies, is projected to achieve a 12% increase in treatment efficacy, reshaping patient care.

By 2026, neural interfaces are poised to revolutionize healthcare and human capabilities in the US, driven by significant technological advancements and a growing focus on ethical integration into society.